Feline hypertrophic cardiomyopathy, Part 3

Feline Practice

Volumn 25, Issue 2, 1997, Pages 22-25

  Behrend, Ellen N ^a,b   Grauer, Gregory F ^a   Greco, Deborah S ^a  

^a Veterinary Dentistry and Oral Surgery   (United States)

^b AUBURN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 21744445711     PISSN: 10576614     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (40)

1. Fox PR: Feline Myocardial Disease. In: Canine and Feline Cardiology. Ed by PR Fox. New York, Churchill Livingstone, 1988, pp 435-466.
2. Atkins CE, Gallo AM, Kurzman ID, Cowen P: Risk Factors, Clinical Signs, and Survival in Cats With a Clinical Diagnosis of Idiopathic Hypertrophic Cardiomyopathy: 74 Cases (1985-1989). JAVMA 201:613-618, 1992.
3. Bond BR, Fox PR: Advances in Feline Cardiomyopathy. Vet Clin North Am (Small Anim Pract) 14:1021-1038, 1984.
4. Gompf RE: Cardiac and Respiratory Involvement in Systemic Diseases and Problems. In: Consultations in Feline Internal Medicine, ed 1. Ed by JR August. Philadelphia, WB Saunders Co, 1991, pp 189-212.
5. Tilley LP, Liu S, Gilbertson SR: Primary Myocardial Disease in the Cat - A Model for Human Cardiomyopathy. Am J Path 86:493-522, 1977.
6. Martin L, VandeWoude S, Boon J, Brown D: Left Ventricular Hypertrophy in a Closed Colony of Persian Cats. Proceedings of the Twelfth Annual Veterinary Medical Forum. San Francisco, CA. American College of Veterinary Internal Medicine, 1994, p 974 (Abstract).
7. Kittleson MD, Pion PD, Mekhamer Y: Hypertrophic Cardiomyopathy in a Group of Highly Interrelated Maine Coon Cats. In: Proceedings of the Eleventh Annual Veterinary Medical Forum. Washington, DC, American College of Veterinary Internal Medicine, 1993, p 930 (Abstract).
8. Bonagura JD: Cardiovascular Diseases. In: The Cat: Diseases and Clinical Management, ed 1. Ed by RG Sherding. New York, Churchill Livingstone, Inc, 1992, pp 649-753.
9. Bright JM, Golden AL: Feline Hypertrophic Cardiomyopathy: Variations on a Theme. In: Proceedings of the Eighth Annual Veterinary Medical Forum. Washington, DC. American College of Veterinary Internal Medicine, 1990, pp 293-296.
10. Liu S, Maron B, Tilley LP: Feline Hypertrophic Cardiomyopathy: Gross Anatomic and Quantitative Histologic Features. Am J Path 102:388-395, 1981.
11. Peterson EN, Moise NS, Brown CA, et al: Heterogeneity of Hypertrophy in Feline Hypertrophic Heart Disease. J Vet Int Med 7:183-169, 1993.
12. Bright JM, Golden AL: Evidence for or Against the Efficacy of Calcium Channel Blockers for Management of Hypertrophic Cardiomyopathy in Cats. Vet Clin North Am (Small Anim Pract) 21:1023-1034, 1991.
13. Bright JM: Update: Diltiazem Therapy of Feline Hypertrophic Cardiomyopathy. In: Kirk's Current Veterinary Therapy XI: Small Animal Practice. Ed by RW Kirk, JD Bonagura. Philadelphia, WB Saunders Co, 1992, pp 766-773.
14. Fox PR: Feline Thromboembolism Associated With Cardiomyopathy. In: Proceedings of the Fifth Annual Veterinary Medical Forum. San Diego, CA. American College of Veterinary Internal Medicine, 1987, pp 714-718.
15. Helenski CA, Ross JN: Platelet Aggregation In Feline Cardiomyopathy. J Vet Int Med 1:24-28, 1987.
16. Medinger TL, Bruyette DS: Feline Hypertrophic Cardiomyopathy. Comp Cont Ed 14:479-492, 1992.
17. Liu S, Tilley LP, Lord PF: Feline Cardiomyopathy. In: Recent Advances in Studies on Cardiac Structure and Metabolism. Volume 10. Ed by P Roy, G Rona. Baltimore, University Park Press, 1975, pp 627-640.
18. Lord PF, Wood A, Tilley LP, Liu S: Radiographic and Hemodynamic Evaluation of Cardiomyopathy and Thromboembolism in the Cat. JAVMA 164: 154-165, 1974.
19. Fox PR: Evidence for or Against Efficacy of β-Blockers and Aspirin for Management of Feline Cardiomyopathies. Vet Clin North Am (Small Anim Pract) 21:1011-1022, 1991.
20. Anfossi G, Mularoni E, Massucco P, et al: Calcium Channel Blocking Agents Verapamil and Diltiaiem Are Inhibitors of Vasopressin-Induced Human Platelet Activation. Clin Exper Pharm Physiol 18:767-773, 1991.
21. Sisson DD, Thomas WP: Myocardial Diseases. In: Textbook of Veterinary Internal Medicine, ed 4. Ed by SJ Ettinger, EC Feldman. Philadelphia, WB Saunders Co, 1995, pp 995-1032.
22. Gwathmey JK, Copelas L, MacKinnon R, et al: Abnormal Intracellular Calcium Handling in Myocardium From Patients With End-Stage Heart Failure. Circ Res 61:70-76, 1987.
23. Morgan JP, Morgan KG: Calcium and Cardiovascular Function. Intracellular Calcium Levels During Contraction and Relaxation of Mammalian Cardiac and Vascular Smooth Muscle as Detected With Aequorin. Am J Med 77 (suppl 5A):33-46, 1984.
24. Wagner JA, Sax FL, Weisman HF, et al: Calcium-Antagonist Receptors in the Atrial Tissue of Patients With Hypertrophic Cardiomyopathy. New Eng J Med 320:755-761, 1989.
25. Bright JM, Golden AL: A Comparison of Calcium Channel Blockers and β-Adrenergic Blockers for Treatment of Feline Hypertrophic Cardiomyopathy. In: Proceedings of the Seventh Annual Veterinary Medical Forum, San Diego, CA. American College of Veterinary Internal Medicine, 1989, pp 847-850.
26. Bright JM, Golden AL, Gompf RE, et al: Evaluation of the Calcium Channel-Blocking Agents Diltiazem and Verapamil for Treatment of Feline Hypertrophic Cardiomyopathy. J Vet Int Med 5:272-282, 1991.
27. Smith FWK: Calcium Channel Blockers in Veterinary Medicine. In: Proceedings of the Tenth Annual Veterinary Medical Forum. San Diego, CA. American College of Veterinary Internal Medicine, 1992, pp 219-221.
28. Harpster NK: Feline Cardiomyopathy. Vet Clin North Am (Small Anim Pract) 7:355-371, 1977.
29. Pion PD, Kittleson MD: Therapy for Feline Aortic Thromboembolism. In: Current Veterinary Therapy X: Small Animal Practice. Ed by RW Kirk. Philadelphia, WB Saunders Co, 1989, pp 295-302.
30. Baty CJ: Beyond Aspirin and Heparin: New Ideas in Prevention of Feline Aortic Thromboembolism. In: Proceedings of the Tenth Annual Veterinary Medical Forum. San Diego, CA. American College of Veterinary Medicine, 1992, pp 222-223.
31. Flanders JA: Feline Aortic Thromboembolism. Comp Cont Ed 8:473-484, 1986.
32. Imhoff RK: Production of Aortic Occlusion Resembling Acute Aortic Embolism Syndrome in Cats. Nature 192:979-980, 1961.
33. Schaub RG, Meyers KM, Sande RD, Hamilton G: Inhibition of Feline Collateral Vessel Development Following Experimental Thrombotic Occlusion. Circ Res 39:736-743, 1976.
34. Greene CE: Effects of Aspirin and Propranolol on Feline Platelet Aggregation. Am J Vet Res 46:1820-1823, 1985.
35. Jones RD, Baynes RE, Nimitz CT: Nonsteroidal Anti-Inflammatory Drug Toxicosis in Dogs and Cats: 240 Cases (1988-1990). JAVMA 201:475-477, 1992.
36. Brown SA: Renal Effects of Nonsteroidal Anti-Inflammatory Drugs. In: Current Veterinary Therapy X: Small Animal Practice. Ed by RW Kirk. Philadelphia, WB Saunders Co, 1989, pp 1158-1161.
37. Brooks PM, Day RO: Nonsteroidal Anti-Inflammatory Drugs - Differences and Similarities. New Eng J Med 324:1716-1723, 1991.
38. Behrend EN, Grauer GF, Greco DS, et al: Comparison of the Effects of Diltiazem and Aspirin on Platelet Aggregation in Cats. Proceedings of the Thirteenth Annual Veterinary Medical Forum. Orlando, FL. American College of Veterinary Internal Medicine, 1995, p 1018 (Abstract).
39. Killingsworth CR, Eyster GE, Adams T, et al: Streptokinase Treatment of Cats With Experimentally Induced Aortic Thrombosis. Am J Vet Res 47:1351-1359, 1986.
40. Schaub RG, Meyers KM, Sande RD: Serotonin as a Factor in Depression of Collateral Blood Flow Following Experimental Arterial Thrombosis. J Lab Clin Med 90:645-653, 1977.